BioPharma
22 July, 2024 | Monday | News
Everest Medicines Doses First Chinese Patient in Global Phase 2b Trial of Zetomipzomib for Lupus Nephritis
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today a...
Lab
25 July, 2024 | Thursday | News
SoniVie Presents Promising REDUCED-1 Study Results for TIVUS™ System at EuroPCR Conference
SoniVie, which has developed a novel proprietary Therapeutic Intra-Vascular Ultrasound System (TIVUS™) to treat a variety of hypertensive disorders, presented on May 15th, 2024 at the EuroPCR confere...
BioTech
19 July, 2024 | Friday | News
Thermo Fisher Scientific and BioCell Innovations Sign MoU to Optimize Lentiviral-Based Immunotherapy Manufacturing in Asia-Pacific
Thermo Fisher Scientific, a global leader in serving science, is excited to announce the signing of a Memorandum of Understanding (MoU) with BioCell Innovations Pte Ltd, a pioneer in lentivirus CAR cons...
Contract Services
23 July, 2024 | Tuesday | News
Agilent Acquires BIOVECTRA for $925 Million, Expanding Biopharma Capabilities
Agilent Technologies Inc. announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing organization, for $925 million. Based in Canada, BIOV...
Consumer Health
25 July, 2024 | Thursday | News
Eisai and EcoNaviSta Join Forces to Develop Dementia Ecosystem in Japan’s Super-Aging Society
Eisai Co., Ltd. and EcoNaviSta Inc. announced that they have entered into a business alliance agreement and commenced collaboration with the aim of building an ecosystem in the area of dementia, which is a pres...
White Paper
29 May, 2024 | Wednesday | Product Spotlight
Discover the Future of Tubing Retention: A Comparative Analysis
Product Spot Light
24 July, 2024 | Wednesday | News
Waters Launches High-Throughput RS-DSC for Biologics Stability Testing
Premium Article
05 March, 2024 | Tuesday | Interaction
Bridging Gaps, Building Futures: Ruth Kuguru’s Approach to Healthcare Solutions in APAC
Bio Invest
22 July, 2024 | Monday | News
Rona Therapeutics Secures $35 Million Series A+ Financing to Advance siRNA Programs
Biopharma APAC Infomercial
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
